Novartis Pharmaceuticals Canada Inc. et al. v. Pharmascience Inc.
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,472,399, 2,590,511 and 2,703,598 (sacubitril/valsartan)
The decision is reported
Meet the team
Mingquan Zhang, Ph.D.